scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.IJANTIMICAG.2010.09.001 |
P698 | PubMed publication ID | 21036547 |
P2093 | author name string | Hui Wang | |
Ziyong Sun | |||
Yingchun Xu | |||
Minjun Chen | |||
Huifen Ye | |||
Yunsong Yu | |||
Bijie Hu | |||
Yuxing Ni | |||
Wenxiang Huang | |||
Qiwen Yang | |||
Yunjian Hu | |||
Robert E. Badal | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Gram-negative bacteria | Q632006 |
bacterial drug resistance | Q64924127 | ||
P304 | page(s) | 507-512 | |
P577 | publication date | 2010-10-30 | |
P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
P1476 | title | Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART) | |
P478 | volume | 36 |
Q38167246 | A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. |
Q34829365 | Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective. |
Q38045609 | Antibiotic resistance amongst healthcare-associated pathogens in China. |
Q40945545 | Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. |
Q38348303 | Bacteriophage therapy against Enterobacteriaceae |
Q35689071 | Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital |
Q34838791 | Clinical importance and epidemiology of quinolone resistance |
Q64053969 | Cross-sectional study of the use of antimicrobials following common infections by rural residents in Anhui, China |
Q38123247 | Current strategies for the treatment of complicated intraabdominal infections |
Q40358195 | Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. |
Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
Q50931903 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 200 |
Q90411027 | In vitro Activity of a New Fourth-Generation Cephalosporin, Cefoselis, Against Clinically Important Bacterial Pathogens in China |
Q85634678 | Molecular characterization of the extended-spectrum beta-lactamase (ESBL)-producing Shigella spp. in Shanghai |
Q41727743 | Severe autogenously fecal peritonitis in ageing Wistar rats. Response to intravenous meropenem |
Q55006206 | Stability of ceftiofur sodium and cefquinome sulphate in intravenous solutions. |
Q84502640 | Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010 |
Q42277917 | TG13 antimicrobial therapy for acute cholangitis and cholecystitis |
Q46770277 | Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. |
Q47140357 | Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients |
Q26782924 | Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options |
Search more.